We are a clinical-stage biopharmaceutical company focused on leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving therapeutics for patients with high unmet medical need.
To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277